Swedish CDMO Recipharm is acquiring Consort Medical, the parent of drug delivery and device maker Bespak and the CDMO Aesica, for roughly $650 million. The deal will make Recipharm a top five global CDMO, able to offer integrated device development and supply combined with commercial scale finished dose manufacturing.   This latest acquisition is set amid continued consolidation in the fragmented CDMO industry, as pharmaceutical companies seek to reduce their fixed costs by rationalizing supply ...